Oncology
A new study published in Science claims that some gut microbes produce a metabolite that boosts the effect of a class of cancer drugs.
A metabolite produced by the gut microbiota increases the risk of colon cancer in mice prone to the disease, a new study has found.
Researchers have found that the development of liver cancer can be associated with alterations of the gut microbiota.
Researchers have found that the gut microbiota and the death of intestinal cells caused by chemotherapy can enhance the immune response of people with colon cancer.
We discussed the role of the microbiome in HPV-positive head and neck cancer patients with Marc Oliva Bernal (Institut Català d’Oncologia, Spain).
Does the microbiota contribute to breast cancer development? We asked this question to Sridhar Mani, from the Albert Einstein College of Medicine in New York (USA).
Researchers have created a catalog of the bacteria associated with all the cancer types. The findings could help to enhance the actions of anticancer drugs.
Researchers developed a new tool to modulate the gut microbiota for neutralizing the tumor-promoting microenvironment.
A new study supports the idea that the gut microbiota composition can vary in abundance and function during the development of colorectal cancer.
According to a new study published in the journal Microbiome, cancer treatment outcomes can be modulated by the levels of specific gut bacteria.
